IVERIC bio Investor Relations Material
Latest events
Q4 2022
IVERIC bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IVERIC bio Inc
Access all reports
IVERIC bio, Inc. is a biopharmaceutical company specializing in the discovery and development of treatments for retinal diseases. The company's focus includes developing therapies for age-related macular degeneration and other ocular conditions that lead to vision loss. IVERIC bio aims to address unmet medical needs in ophthalmology through innovative research and targeted approaches to eye health. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ISEE
Country
🇺🇸 United States